Company profile
UK company 11609215, incorporated on 8 October 2018.
Gilead Sciences, Inc.
Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Company number 11609215
Reference milestones and recent Companies House filing stream events.
Company registered at Companies House
MiroBio develops pharmaceuticals aimed at treating autoimmune and inflammatory disorders.
The company is producing new treatments for autoimmunigty based on insights we have obtained into signaling by lymphocytes.
Employment of 10-20 staff currently. Raised £27m in capital from UK and US funders.
The company initiated its first clinical trial in August 2022. It was purchased by Gilead Sciences in August 2022.
The company is still in its development phase.
